NEW YORK, December 14, 2016 /PRNewswire/ --
ChineseInvestors.com (OTCQB: CIIX) ("CIIX" or the "Company"), the premier financial information website for Chinese-speaking investors in both the U.S. and China, and a well-known Cannabidiol (CBD) health brand engaged in the development, manufacturing, marketing and distribution of consumer products containing CBD, today announced a new wholesale agreement that enables CIIX to retail nutritional supplements containing CBD to the Asian market through both online and in-store sales. The CBD company's flagship product is the top-selling brand of hemp-derived CBD oil for consumers in the natural products industry. This leading brand has not only built a reputation for product quality, safety and efficacy, but also offers the most diverse and largest supply of hemp-derived CBD oil on hand in the United States.
CBD oil is a natural concentrate extracted from cannabis and is considered a food nutrient delivering the benefits of cannabinoids without the psychotropic effects of THC. It has been legalized in the 50 states of the U.S., and can also be exported to more than 40 countries including China. The primary function of CBD oil is to protect the brain and nervous system, help digestion problems, relieve pain and reduce anxiety and stress. This concentrate can be widely used in nutrition supplements, skin care products, normal beverages and functional beverages, and can be sold through either the traditional or direct sales method.
Warren Wang, founder and CEO of CIIX, commented: "As more and more states in the U.S. legalize the use of either medical or recreational cannabis, CBD supplements have become a hot spot in the health products market. ChineseInvestors.com is very pleased to enter into a new wholesale agreement with a well-known manufacturer of the top-selling brand of CBD Oil. Through this mutually beneficial partnership, we can positively open the Chinese market in the U.S. and the markets in Asia for CBD products, and continue exploring investment opportunities that further expand our business in the cannabis industry."
Mr. Wang further remarked: "According to The CBD Report published by The Hemp Business Journal, Cannabidiol is one of the fastest growing market categories in the U.S. hemp and legal marijuana industries with a compound annual growth rate of 59%. In 2015, the CBD industry grew from a nearly invisible market a few years ago to $202 million in consumer sales, and it is further expected to grow to $2.1 billion in consumer sales by 2020. Because the Asian market has a prospective consumer base of 4.4 billion people, we are confident that our first step to partner with the leading manufacturer of CBD oil in the world today could have potentially towering profit opportunities."
About ChineseInvestors.com (OTCQB: CIIX):
ChineseInvestors.com, Inc. ('CIIX'), founded in 1999 endeavors to be an innovative company; providing (a) real-time market commentary, analysis, and educational related services in Chinese language character sets (traditional and simplified), (b) support services to our various partners, (c) consultative services to smaller private companies considering becoming a public company, (d) advertising and public relation related support services, and (e) other services we may identify having the potential to create value or partnership opportunity with our existing services.
Subscribe and watch our video commentaries: https://www.youtube.com/user/Chinesefncom
Follow us on Twitter for real time Company updates: https://twitter.com/ChineseFNEnglsh
Facebook Like us to receive live feeds: https://www.facebook.com/Chinesefncom
Add us on WeChat at: Chinesefn or download iPhone iOS App: Chinesefn.
14 Wall Street 20th Floor
New York, NY 10005
Office Tel: +1-800-958-8561
SOURCE ChineseInvestors.com, Inc